USPTO serial 79048077
SPECIALITY EUROPEAN PHARMA
Reviewed by CopyMark Law Group
Reg. 3537335Status 404
- Filing date
- Status date
- Registration date
- Nov 25, 2008
- Examiner
- HELLMAN, ELI J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SPECIALITY EUROPEAN PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
David I. Greenbaum
David I. Greenbaum Edwards Wildman Palmer LLPPO Box 130FDR StationNew York, NY 10150Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in oncology, pharmaceutical preparations for the diagnosis or treatment of diseases and disorders, namely, neurological, dermatological, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory disorders, immune system disorders including autoimmune diseases, metabolic disorders, psychiatric disorders, allergic reactions, infectious diseases, occular disorders, multiple sclerosis, amyotrophic lateral sclerosis (ALS), Huntingdon's disease, spinal muscular atrophy, adenomatous polyposis coli, reproductive disorders, endocrinology disease, urological disorders, respiratory disorders, asthma, allergies, cancers, infectious organisms, bacterial infections, drug resistance, bacterial drug resistance, metabolic disorders, inflammation, cardiovascular diseases, viral infections, gene therapy treatments, viral latency, genetic disorders, sickle cell anaemia, restenosis, thallasemia, bacterial infections, diabetes, central nervous system disorders and diseases, depression, schizophrenia, obesity, parasitic infections, fungal infections, skin diseases, arthritis, osteoporosis, circulatory diseases, degenerative disorders, autoimmune disease, gastrointestinal disorders and diseases, musculoskeletal disorders and diseases, renal disease, connective tissue and joint disease, eye disease | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Speciality European Pharma Limited
- Other trademarks owned by Speciality European Pharma Limited
- Other trademarks owned by Speciality European Pharma Limited
- Other trademarks in Class 005
- Similar marks named SPECIALITY EUROPEAN PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 29, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jun 29, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Mar 31, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 22, 2016 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 22, 2016 | INPC | INVALIDATION PROCESSED | — |
| Feb 26, 2016 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 10, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 26, 2015 | C71T | CANCELLED SECTION 71 | — |
| Jan 7, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 30, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 18, 2009 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 18, 2009 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 26, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 25, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 9, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 20, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Aug 5, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 5, 2008 | ALIE | ASSIGNED TO LIE | — |
| Aug 4, 2008 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2008 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 31, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 6, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 6, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 6, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 26, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 26, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 26, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 25, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 1, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Jan 31, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |